Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100045458Phase 4Recruiting
Phase 4 trial of dexmedetomidine (2 arms), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoints: Sedation score, Corticotropin and 1 more. Started May 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100045458.